相关实验视频
Updated: Jun 23, 2025
07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
68
可注射的酸盐-原药小粒诱导长效免疫调节,并预防小鼠自身免疫性关节炎
Shijie Cao1, Erica Budina2, Ruyi Wang3
1Pritzker School of Molecular Engineering, University of Chicago, Chicago, IL 60637, United States; Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, WA 98195, United States.
概括
这项研究开发了一种新的淋巴输送系统,用于治疗类风湿性关节炎的短链脂肪酸 (SCFA) - - 丁酸. 这种新方法有效地向免疫细胞,防止自身免疫性疾病的发生.
科学领域:
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
- 药理学 药理学是指药理学的学科.
背景情况:
- 短链脂肪酸 (SCFA),像丁酸盐一样,具有有利于免疫平衡的免疫调节性质.
- 由于需要频繁,高剂量的口服剂量,SCFA的临床使用受到阻碍.
- 类风湿性关节炎 (RA) 涉及异常的T细胞和骨髓细胞激活.
研究的目的:
- 开发一种基于菌的丁酸盐原药,用于直接输送淋巴.
- 为了实现长期的免疫调节作用,并克服口服SCFA的局限性.
- 在类风湿性关节炎小鼠模型中研究治疗潜力.
主要方法:
- 一种基于聚合物菌根的丁酸盐原药的配方.
- 通过皮下注射给药负电荷小粒 (Neg-ButM).
- 在原抗体诱导性关节炎 (CAIA) 鼠标模型中评估细胞向,在淋巴器官中保留,以及治疗疗效.
主要成果:
- 在皮下注射后,Neg-ButM在淋巴结,脏和肝脏中显示出优异的淋巴向和长时间的保留 (>1个月).
- 在CAIA小鼠模型中,两次分离注射Neg-ButM有效地预防了疾病的发病.
- 治疗促进了T细胞和髓状细胞在局部和全身上都具有耐受性的表型.
结论:
- 使用小胞纳米颗粒的淋巴递送丁酸盐是一种有前途的策略,用于管理炎症性自身免疫性疾病,如RA.
- 这种方法为频繁的口服剂量提供了潜在的替代方案,提高了治疗疗效.
- 通过淋巴输送直接调节免疫反应,代表了一种新的治疗途径.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
156
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
156
01:29Drugs for Treatment of Ulcerative Colitis in IBD
135
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
135
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
130
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
130